AtriCure to Present at Thomas Weisel Partners 2007 Healthcare ...( WEST CHESTER Ohio Aug. 30 /- Atri...),Health

WEST CHESTER, Ohio, Aug. 30 /PRNewswire-FirstCall/ -- AtriCure, Inc. (Nasdaq: ATRC), a medical device company focused on developing, manufacturing and selling innovative cardiac surgical devices, announced today that David J. Drachman, President and Chief Executive Officer, is scheduled to present at the Thomas Weisel Partners 2007 Healthcare Conference at the Four Seasons Hotel in Boston on Wednesday, September 5th, at 9:45 a.m. ET.

A live Web cast and recording of the presentation will be available on the Investor Relations page of AtriCure's Web site at http://www.atricure.com. After the live Web cast, the presentation will remain available on AtriCure's Web site for 30 days.

About AtriCure, Inc.

AtriCure, Inc. is a medical device company focused on developing, manufacturing and selling innovative cardiac surgical devices designed to create precise lesions, or scars, in cardiac and soft tissues. Medical journals have described the adoption by leading cardiothoracic surgeons of the AtriCure Isolator(R) bipolar ablation clamps as a treatment alternative during open-heart surgical procedures to create lesions in cardiac, or heart, tissue to block the abnormal electrical impulses that cause atrial fibrillation, or AF, a rapid, irregular quivering of the upper chambers of the heart. Additionally, leading cardiothoracic surgeons have described the AtriCure Isolator(R) bipolar ablation clamps as a promising treatment alternative for patients who may be candidates for sole-therapy minimally invasive procedures. AF affects more than 2.5 million Americans and predisposes them to a five-fold increased risk of stroke.

The FDA has cleared the AtriCure I
'/>"/>